Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pattern of recurrence after stereotactic body radiotherapy for para-aortic oligo-recurrent prostate cancer, a multicentric analysis.
Francolini G, Garlatti P, Di Cataldo V, Triggiani L, Simoni N, Detti B, Lorenzetti V, Colombo F, Morelli V, Ganovelli M, Caprara L, Orsatti C, Burchini L, Frosini G, Bertini N, Loi M, Simontacchi G, Greto D, Desideri I, Meattini I, Livi L. Francolini G, et al. Among authors: garlatti p. Radiol Med. 2023 Nov;128(11):1423-1428. doi: 10.1007/s11547-023-01701-x. Epub 2023 Aug 19. Radiol Med. 2023. PMID: 37597125
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors.
Mangoni M, Sottili M, Salvatore G, Meattini I, Desideri I, Greto D, Loi M, Becherini C, Garlatti P, Delli Paoli C, Dominici L, Gerini C, Scoccianti S, Bonomo P, Silvano A, Beltrami G, Campanacci D, Livi L. Mangoni M, et al. Among authors: garlatti p. Radiat Res. 2018 Nov;190(5):464-472. doi: 10.1667/RR15035.1. Epub 2018 Aug 1. Radiat Res. 2018. PMID: 30067444
A matched cohort study of radio-chemotherapy versus radiotherapy alone in soft tissue sarcoma patients.
Greto D, Loi M, Terziani F, Visani L, Garlatti P, Lo Russo M, Teriaca A, Muntoni C, Delli Paoli C, Topulli J, Campanacci D, Beltrami G, Scoccianti G, Bonomo P, Desideri I, Francolini G, Livi L. Greto D, et al. Among authors: garlatti p. Radiol Med. 2019 Apr;124(4):301-308. doi: 10.1007/s11547-018-0939-7. Epub 2018 Sep 12. Radiol Med. 2019. PMID: 30209796
Influence of age and subtype in outcome of operable liposarcoma.
Greto D, Saieva C, Loi M, Terziani F, Visani L, Garlatti P, Lo Russo M, Muntoni C, Becherini C, Topulli J, Campanacci D, Beltrami G, Scoccianti G, Muratori F, Bonomo P, Desideri I, Francolini G, Livi L. Greto D, et al. Among authors: garlatti p. Radiol Med. 2019 Apr;124(4):290-300. doi: 10.1007/s11547-018-0958-4. Epub 2018 Nov 12. Radiol Med. 2019. PMID: 30421387
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial.
Becherini C, Meattini I, Livi L, Garlatti P, Desideri I, Scotti V, Orzalesi L, Sanchez LJ, Bernini M, Casella D, Nesi S, Nori J, Bianchi S, Pallotta S, Marrazzo L. Becherini C, et al. Among authors: garlatti p. Tumori. 2019 Jun;105(3):205-209. doi: 10.1177/0300891618811278. Epub 2018 Nov 26. Tumori. 2019. PMID: 30474504 Clinical Trial.
Efficacy and Tolerability of CyberKnife Stereotactic Robotic Radiotherapy for Primary or Secondary Orbital Lesions: A Single-Center Retrospective Experience.
Desideri I, Francolini G, Carta GA, Di Cataldo V, Masi L, Meattini I, Bonomo P, Loi M, Greto D, Visani L, Lo Russo M, Grassi R, Teriaca MA, Garlatti P, Nardi C, Livi L. Desideri I, et al. Among authors: garlatti p. Technol Cancer Res Treat. 2019 Jan 1;18:1533033818818561. doi: 10.1177/1533033818818561. Technol Cancer Res Treat. 2019. PMID: 30803353 Free PMC article. Clinical Trial.
Thermal Ablation versus SBRT in liver tumours: pros and cons.
Loi M, Desideri I, Dominici L, Francolini G, Garlatti P, Ciccone LP, Stocchi G, Salvestrini V, Meattini I, Livi L. Loi M, et al. Among authors: garlatti p. Med Oncol. 2020 Apr 29;37(6):52. doi: 10.1007/s12032-020-01377-7. Med Oncol. 2020. PMID: 32350765 Review.
19 results